• Teamwork essential if oral PCa agents are used in office setting

    3 days ago - By Modern Medicine

    Gwendolyn Hooper, PhD, APRN, is president of the Society of Urologic Nurses and Associates and assistant professor at the University of Alabama, Tuscaloosa.
    A recent Urology Times article reporting on results of a survey on the experience of Canadian urologists in integrating abiraterone acetate into the urology practice suggests that other forms of chemotherapy are at least being investigated for office use, barring reimbursement issues. Although many offices are familiar with managing prostate cancer patients with anti-androgens, oral androgen receptor inhibitors such as abiraterone are...
    Read more ...